The $11 Million Question Facing Milwaukee County
Milwaukee County’s budget process, typically a dry exercise in municipal accounting, collided head-on this week with the skyrocketing national demand for GLP-1 weight loss medications. As the County Board of Supervisors grappled with a multi-million dollar deficit, the sheer volume of employees utilizing these drugs—which include popular treatments like Wegovy and Zepbound—brought the fiscal reality of modern healthcare costs into sharp focus. According to reporting from WISN, the county spent $11 million this year alone on GLP-1 medications for employees covered under its insurance plans.
Board Votes on Rolland Amendment to Patch Budget Hole
The debate reached a fever pitch on Thursday when the Board of Supervisors voted on an amendment authored by Supervisor Shawn Rolland. The proposal sought to address a $4.5 million budget hole that officials reportedly discovered only recently. Rolland’s plan was twofold: it would have increased the employee copay for GLP-1 medications from $40 to $150 per month, and it would have restricted coverage exclusively to those with a clinical diagnosis of diabetes.
“Because we need to find $4.5 million to patch a hole that we had no idea about until yesterday,” Supervisor Shawn Rolland said during the debate.
The proposal failed to gain enough support to pass, leaving the county’s current insurance structure intact for now.
The Human and Economic Stakes
“I see this is just going to explode; it’s just not going to stop,” Wasserman said.
A Regional Context of Health and Budgeting
Wasserman pointedly noted that Wisconsin currently ranks as the ninth heaviest state in the country, framing the county’s high medication usage as both a health necessity and a systemic financial vulnerability. The failure of the amendment does not close the door on the issue. With projections indicating that the cost for these medications could rise by another $4 million in the coming year, the Board of Supervisors will almost certainly revisit the topic.
